EIZO (6737) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
30 Oct, 2026Strategy and growth priorities
Focus on safety, healthcare and critical infrastructure, delivering reliable imaging, customized solutions, and long-term lifecycle support for customer decision-making.
Direct investment toward healthcare surgery and treatment, security and surveillance, and defense; optimize core markets for sustainable profit and streamline B&P and Creative Work to improve profitability.
Expand EVS imaging solutions, global video transmission and recording, regional system businesses, and software capabilities; pursue potential M&A and invest in people and sustainability.
Financial targets and market mix
FY2029 net sales target ¥94.0bn versus FY2026 plan ¥85.0bn, up ¥9.0bn or 10.6%; operating profit target ¥8.0bn versus ¥3.3bn, up ¥4.7bn or 142.4%.
FY2029 operating margin target 8.5% versus FY2026 plan 3.9%; net income target ¥11.0bn versus ¥6.5bn, including gains on investment-security sales; ROE target 8.0% versus FY2025 actual 5.6%.
FY2029 sales targets: healthcare ¥43.2bn, V&S ¥23.8bn, B&P/Creative Work ¥18.6bn, and amusement ¥8.4bn, compared with FY2026 plans of ¥37.8bn, ¥15.7bn, ¥20.9bn, and ¥10.6bn, respectively.
Segment strategies
Healthcare targets ¥43.2bn sales in FY2029; priorities include AI-enabled quality control, digital pathology, software and services, broader surgical-monitor offerings, OR imaging integration, and stronger North American, Chinese, and Indian sales.
V&S targets ¥23.8bn sales in FY2029; invest in R&D, technical sales, and global reach, commercialize AI-enabled imaging, expand SI partnerships, and strengthen regional sales and service networks.
B&P/Creative Work targets ¥18.6bn sales in FY2029; focus on high-value products, TCO and sustainability value, lineup optimization, stronger target-market focus, and advanced imaging and color-management solutions.
Amusement targets ¥8.4bn sales in FY2029; shift from unit-volume dependence to value creation, using integrated hardware and software capabilities to support earnings as the market gradually contracts.
Latest events from EIZO
- V&S-led growth lifted H1 sales; procurement uncertainty kept FY2027 guidance unchanged.6737
Q2 2027 - Sales and profit surged on overseas growth, forex gains, and expanded share buybacks.6737
Q1 2027 - Profit attributable to owners surged 76.5% year-over-year on stable sales and investment gains.6737
Q4 2026 - Profits fell on weak demand, but full-year growth and a share split are forecast.6737
Q1 2025 - Profits and comprehensive income fell sharply, with a modest sales outlook and share split enacted.6737
Q2 2025 - Profits dropped despite stable sales, with unchanged guidance and a recent share split.6737
Q3 2025 - Flat sales and lower profit, but FY2026 outlook targets growth and higher dividends.6737
Q4 2025 - Sales and profits fell on European weakness, but margin and new products support future outlook.6737
Q1 2026 - Healthcare and Amusement drove 2.9% sales growth, but profits were pressured by higher SG&A.6737
Q2 2026